|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Alexander, E. Russell, 343 “All-hazards” approach, 56, 292n American Academy of Family Physicians, 89 American Accreditation HealthCare Commission, 218 American College of Emergency Physicians (ACEP), 52 American College of Occupational and Environmental Medicine, 52 American Hospital Association (AHA), 52 American Medical Association, 218 American Medical Group Association, 217 American Nurses Association (ANA), 52 American Public Health Association, 24, 52, 89, 305 ANA. See American Nurses Association Announcement, of the smallpox vaccination program, 41–42 Anthrax bioterrorism attacks within the U.S., xv, 23, 305 Antiviral agents, need for development of, 11 Antiviral T-cell response, 14 Areas of potential future inquiry, 158–159 Assessment of Future Scientific Needs for Variola Virus, 11 Assessment of safety profile, 142–149 Association of Federal, State, County, and Municipal Employees, 52 Association of Professionals in Infection Control, 218 Association of Public Health Laboratories, 24 Association of State and Territorial Health Officials (ASTHO), 24, 49, 51, 54, 83, 86, 91, 94, 98, 100, 197, 236n ASTHO. See Association of State and Territorial Health Officials Atlanta, Georgia, official repository for live variola virus, 11 Authority. See also Responsibility CDC needing to speak with, 82–83, 89, 95–96, 101, 114, 155, 209–210 for decision-making, clear lines of, 257, 299 documentation of, 278 Availability of compensation, notification about, 189–190 of vaccinations for the general public, 31, 33 of vaccine supplies in the United States, 15–16 Aventis Pasteur vaccine, 15, 17 B Background rates, of conditions that could be confused with adverse reactions, 146–147 Bangladesh, smallpox in, 18 Baxter Healthcare Corp., 16 Bayer, Ronald, 344 Bifurcated needle call for a safer, 52 inoculation using, 14 invention of, 10 See also Bioterrorism, preparing for Bioterrorism. See also Biopreparedness agents that could be used in, 205 contrasting roles of public health and traditional responders in, 291 funding for, 33–34 grants for, 87 media role in, 218 only one public health threat, 268 possibility of future, 23 preparing for, 34–35, 81, 172–174, 217, 266 response competencies, 281 university-based centers for studying, 218 Blood donation forms, 141 Bush, George W., xv, 9, 26, 41, 52, 84, 124–125, 137, 222 C Cardiac adverse events, 40, 46–48, 90 Cardiac disease, basic pathophysiology of, 236 Cardiomyopathy, 229 dilated, 241 Category A pathogens, 23 CDC. See Centers for Disease Control and Prevention CDC-American Medical Association First National Congress on Public Health Readiness, 99 CDC Clinician Information Line, 176, 178, 180, 230 CDC/Department of Health and Human Services (DHHS) guidance, 211, 214–215, 281
|
|
|||||||||||||||
